Genetic Analysis AS
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
GEAN | SPGR
Overview
Corporate Details
- ISIN(s):
- NO0010692130 (+2 more)
- LEI:
- 5493004G3I23R6STCD61
- Country:
- Norway
- Address:
- Ulvenveien 80B, 0581 Oslo
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Genetic Analysis AS is a research-driven diagnostics company specializing in the human microbiome market. The company develops and commercializes diagnostic solutions based on its proprietary GA-map® platform, a standardized technology for characterizing the microbiome. Its flagship product is the GA-map® Dysbiosis Test Lx, a CE-marked in-vitro diagnostic test used to identify and characterize gut bacterial imbalances (dysbiosis) in patients with conditions such as IBS and IBD. Genetic Analysis serves laboratory diagnostics, clinical research, and pharmaceutical clients, offering tools for routine testing and the co-development of companion diagnostics to support targeted drug therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Genetic Analysis AS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genetic Analysis AS
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genetic Analysis AS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
